Background {#Sec1}
==========

A femoral neck fracture (FNF) is one of the most common and devastating injuries encountered by orthopedic surgeons. Over 150,000 femoral neck fractures occur every year in the USA, and this number will double by 2050 \[[@CR1]--[@CR3]\]. In the Garden classification, Garden I and II fractures describe undisplaced FNFs in older patients \[[@CR4]--[@CR6]\]. The treatment options are conservative (bed rest with or without traction) and surgical (internal fixation) \[[@CR7]\]. Surgical treatment was reported to be optimal \[[@CR8]\]. However, any surgery is associated with some risk. Patients undergoing conservative treatment enjoyed good outcomes in some studies \[[@CR9]\].

Taha et al. found that conservative therapy afforded an undisplaced FNF union rate of only 44.3% \[[@CR10]\]. Ma et al. and Buord et al. reported that the secondary displacement rates during conservative therapy were 41 and 33%, respectively \[[@CR11], [@CR12]\]. However, Raaymakers et al. found that conservative treatment was successful in 85.9% of patients \[[@CR9]\]. Surgery also seemed to be a good option, reducing secondary displacement and the non-union rate. Phillips et al. found that the union rate after surgery was 94.4% \[[@CR13]\]. Chen et al. reported a union rate of 94.6% \[[@CR14]\]. However, up to 22.5% of patients experienced avascular femoral head necrosis after surgery, and a fixation failure problem was also apparent \[[@CR13]\].

Several retrospective studies have compared surgery and conservative therapy to treat undisplaced FNF. The three studies of Bentley et al., Manninger et al., and Cserhati et al. recommended surgical treatment of undisplaced FNFs; this was associated with earlier rehabilitation, lower complication rates, and higher functional scores \[[@CR15]--[@CR17]\]. However, of a total of 54 undisplaced FNF patients, Helbig et al. found that 24 (44%) developed no complications at all during conservative treatment whereas 28 (52%) required surgery because of early fracture dislocation \[[@CR18]\]. No difference between conservative and operative treatment was evident in terms of survival rate, outcome score, or patient satisfaction.

The purpose of this systematic review was to assess all available clinical data on outcomes after surgery and conservative therapy to treat undisplaced FNFs; we mainly focused on the rates of bone union, secondary displacement, and avascular necrosis (AVN).

Methods {#Sec2}
=======

Literature search {#Sec3}
-----------------

The following sources of data were searched up to 1 October 2016 by three reviewers (DFX, CHZ, CHM): EMBASE, PubMed, OVID, Cochrane Library, Web of Science, Scopus, using the search strategy of (((femoral neck fracture \[MeSH Terms\]) OR (femoral neck fracture \[Title/Abstract\])) AND ("Garden I" OR "Garden II" OR "undisplaced" OR "non-displaced")) with no limitation on the year or language of publication. Bibliographies of all the retrieved articles were hand-searched. In addition, we searched Clinical Trial Registry, Current Controlled Trials, Trials Central, Centre Watch, Google Scholar, multiple Websites of orthopedic associations, and conference proceedings for gray literatures. In the papers, we reviewed the references for any other papers we may not have found.

Selection criteria {#Sec4}
------------------

The inclusion criteria for the studies were (1) patients with an undisplaced (Garden type I or Garden type II) femoral neck fracture; (2) primarily conservative treatment; (3) primarily surgical treatment; (4) the outcomes reported at least one of the following assessments: time to union, time to weight bearing, secondary displacement, non-union, AVN, and other complications; and (5) RCTs, non-randomized or quasi-randomized controlled trials, prospective cohort trials, or retrospective comparative studies.

The exclusion criteria were (1) displaced femoral neck fracture; (2) case report, reviews, biomechanical, animal study; (3) patients and fracture that had previously been reported; (4) follow-up \<6 months; and (5) sample size of \<10.

Data abstraction and analysis {#Sec5}
-----------------------------

Three reviews (DFX, FGB, CYM) extracted relevant data and checked the accuracy independently. Specially, study design and level of evidence, patient demographics (sample size, age, gender), mean follow-up time, loss to follow-up rate, intervention (technique and treatment protocol), and outcome measurements were all abstracted. The authors of the included trials were written to identify duplicate publication and uncertain data if necessary.

The weighted kappa for the agreement on the study quality between the investigators was 0.85 (95% confidence interval (CI), 0.77--0.93).

Assessment of trial quality {#Sec6}
---------------------------

Two reviewers (DFX and ZFW) independently assessed the methodological quality of each trial with the modified Critical Appraisal Skills Programme (CASP) \[[@CR19]\]. Each trial was scored with 12 questions, for which the score was 1 for "Yes" and 0 for "No" or "Can't tell". Disagreement was evaluated by means of kappa (*κ*) test and resolved by discussion.

Statistical analysis {#Sec7}
--------------------

All the results were combined and present as the mean value. The rates of union, secondary displacement and non-union, avascular necrosis, bed rest-related complications, 1 year mortality and reoperation could be combined for statistical analysis. Chi-square test and Fisher's exact test were used to detect the difference of the latter two indices between the two treatment groups. The cutoff value of statistically significant difference was adjusted as *α'* = *α*/\[(*k*/2) + 1\] = 0.05/\[(4/2) + 1\] = 0.017, where *k* was the number of groups. The pooling of the functional assessment data sets was not attempted because of the significant variability in the criteria. Statistical analyses were performed through STATA 12.0 (Stata Corp., College Station, TX, USA).

Results {#Sec8}
=======

Study identification {#Sec9}
--------------------

The initial literature search yielded 1024 articles including 466 duplicates, after the removal of which 558 articles remained. Of these, 429 were excluded because they did not fulfill our selection or exclusion criteria based on evaluation of the titles and abstracts. The full texts of the remaining 129 papers were reviewed, and 31 \[[@CR9]--[@CR15], [@CR17], [@CR20]--[@CR28]\] (Fig. [1](#Fig1){ref-type="fig"}) were finally included; these dealt with patients with undisplaced FNFs who were managed either non-operatively or operatively. After careful inspection, we found that \>50% of the patients were lost to follow-up in the study of Manninger et al. \[[@CR16]\] Additionally, in another study, patients in the surgical group had initially received conservative therapy \[[@CR18]\]. We excluded both studies; 29 studies thus remained.Fig. 1A PRISMA flowchart illustrated the selection of studies included in our systematic review

Patient characteristics and interventions {#Sec10}
-----------------------------------------

Table [1](#Tab1){ref-type="table"} shows the patient characteristics and the interventions used in all trials. There were 5 prospective cohort studies \[[@CR9], [@CR12], [@CR23], [@CR27], [@CR29]\] and 24 retrospective cohort studies \[[@CR10]--[@CR15], [@CR17], [@CR20]--[@CR22], [@CR24]--[@CR26], [@CR28], [@CR30]--[@CR40]\]. Of the 29 studies, 2 \[[@CR15], [@CR17]\] compared both therapies, 7 \[[@CR9]--[@CR12], [@CR26]--[@CR28]\] explored the outcomes of conservative treatment, and 20 \[[@CR13], [@CR14], [@CR20]--[@CR25], [@CR29]--[@CR40]\] the outcomes of surgery. The surgical options included the use of cancellous screws, single Watson-Jones nails, placement of three Knowles pins, use of a dynamic hip screw, and Smith-Petersen nails. All trials recruited \>10 patients. In total, 5071 cases were included, of which 1120 were conservatively and 3951 surgically treated. The vast majority of patients were female (female/male = 3211/1280). Four papers did not indicate the gender distributions \[[@CR27], [@CR32], [@CR35], [@CR39]\]. The mean follow-up duration was \>28.3 months. The frequency-weighted mean age was 75.0 ± 4.8 years for the conservatively treated group and 76.5 ± 4.1 years for the surgically treated group.Table 1Study characteristics and intervention of the trials with operation or non-operation or comparisonStudyLevelPatients/casesMean age (years)F/MFollow-up (months)Garden I/Garden IITreatmentComparison studies Bentley \[[@CR1]\]IV43/437258/8\>36NRConservation23/23\>36NR20 Smith-Petersen nailing, 2 three Moore pins, 1 Charnley compression screw Cserhati \[[@CR2]\]IV122/12274.698/24NR106/16Conservation125/12573.3104/21NR98/2719 two Smith-Petersen nail, 5 three cannulated screws, 95 three screws + key-hole plage, 6 othersConservative treatment studies Ma \[[@CR3]\]IV115/1157188/27NR115/0 Jensen \[[@CR4]\]IV128/12873101/272285/43 Buorda \[[@CR5]\]III57/5781.850/720NR Taha \[[@CR6]\]IV61/618348/13NRNR Raaymakers \[[@CR7]\]III170/17069.8130/40NR167/0 Raaymakers \[[@CR8]\]III319/31972NRNR311/0 Verheyen \[[@CR9]\]IV105/1057883/22NR105/0Operative treatment studies Rogmark \[[@CR10]\]IV224/22481156/6832NRTwo Hansson hook pins Lapidus \[[@CR11]\]III382/38280.7282/10079.2NROlmed screws Han \[[@CR12]\]IV52/5277.638/1411.713/39Multiple screws, pins, or dynamic hip screw Phillips \[[@CR13]\]IV100/10076.986/1422.6NRWatson-Jones nail fixation Manohara \[[@CR14]\]IV100/1007877/233985/15Screws Kim \[[@CR15]\]IV60/6077.540/1846.828/30Three cannulated screws Chiu \[[@CR16]\]IV298/30566197/10175NRKnowles pins Chen \[[@CR17]\]IV37/3783.722/15\>2421/16Cancellous screws Makki \[[@CR18]\]IV31/317522/9\>122/26Dynamic hip screw34/347020/14\>129/25Dynamic hip screw with anti-rotation screw Parker \[[@CR19]\]IV346/34680.8295/51\>12NRScrew346/34680.8295/51\>12NRHemiarthroplasty Stromqvist \[[@CR20]\]IV85/8578NR\>12NRHook Pin Parker \[[@CR21]\]IV565/56576435/130\>12NRA sliding hip\
screw or three cannulated screws Parker \[[@CR22]\]IV112/11276NR24NRInternal fixation Lee \[[@CR23]\]IV28/2870.118/15\>12NRDynamic hip screw22/2274.613/12\>12NRDynamic hip screw27/2772.815/17\>12NRMultiple cannulated screws Hui \[[@CR24]\]IV15/15\>80NR\>6NROver 80 years internal fixation16/1672NR\>6NR65--79 years internal fixation23/23\>80NR\>6NROver 80 years hemiarthroplasty Bjorgul \[[@CR25]\]IV225/22580161/6447NRTwo cannulated screws Watson \[[@CR26]\]III31/3177.925/6\>24NRDynamic hip screw29/2976.724/5\>24NRThree partially threaded screws Yih \[[@CR27]\]IV46/4672.824/1633.5NRDynamic hip screws48/4870.625/1935.6NRMultiple cannulated screws Conn \[[@CR28]\]IV375/37577.175/296\>12NRThree parallel Sikand \[[@CR29]\]IV29/297921/8\>12NRHemiarthroplasty110/1107785/25\>12NRInternal fixation*NR* not recorded

Outcomes {#Sec11}
--------

Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} show the outcome measurements of all trials. All trials reported secondary displacement and/or non-union rates, and those of later AVN. Fourteen studies \[[@CR9]--[@CR11], [@CR13]--[@CR15], [@CR20], [@CR25]--[@CR28], [@CR33], [@CR34], [@CR40]\] reported union rates. These were 68.8% (642/933) in those receiving conservative treatment and 92.6% (635/686) in those receiving surgical treatment. The secondary displacement rate was 30.0% (334/1112) in conservatively treated patients compared to 0.57% (12/2124) in surgically treated patients. The AVN rate was 10.3% (39/380) in conservatively treated patients compared with 7.7% (159/2074) in surgically treated patients. The re-operation rate was 22.6% (157/696) in conservatively treated patients compared with 10.6% (336/3155) in surgically treated patients. Bed rest-related complications developed in 11.4% (27/237) of conservatively treated patients compared with 4.9% (106/2149) of surgically treated ones. The 1-year mortality was 14.7% (125/852) in conservatively treated patients compared with 18% (598/3318) in surgically treated ones.Table 2Details of outcome measurements of the trialsStudyTreatmentUnionSecondary displacementNon-unionFixation failureAvascular necrosisBed rest-related complications1 year mortalityRe-operationReduction in mobility statusLocal painComparison studies Bentley \[[@CR1]\]Conservation83.7%(36/43)16.3%(7/43)2.3%(1/43)NR14.0%(6/43)NRNR14%(5/43)NRNRPetersen nailing, Moore pins95.7%(22/23)0(0/23)4.3%(1/23)4.3%(1/23)17.4%(4/23)NRNR0(0/23)NRNR Cserhati \[[@CR2]\]ConservationNR19.7%(24/122)0.8%(1/122)NR12.8%(5/39)18.9%(23/122)13.9%(17/122)18%(22/122)25.6%(10/39)51.3%(20/39)Petersen nail, three screws + key-hole plageNR0.8%(1/125)0(0/125)0.8%(1/125)16.1%(10/62)3.2%(4/125)10.4%(13/125)NR45.2(28/62)61.3%(38/62)Conservative treatment studies Jensen \[[@CR3]\]Conservation72.7%(93/128)27.3%(35/128)NRNRNRNRNRNRNRNR Ma \[[@CR4]\]Conservation58.3%(67/115)41.7%(48/115)NRNRNR3.5%(4/115)3.5%(4/115)41.7%(48/115)NRNR Raaymakers \[[@CR5]\]Conservation69%(216/311)31%(95/311)NRNR11.3%(18/160)NR19.1%(61/319)10.6%(33/311)NRNR Raaymakers \[[@CR6]\]Conservation85.9%(146/170)14.1%(24/170)NRNR11.1%(9/81)NR16.5%(28/170)NRNRNR Verheyen \[[@CR7]\]Conservation54.3%(57/105)45.7%(48/105)NRNRNRNRNR45.7%(48/105)NRNR Buorda \[[@CR8]\]ConservationNR33.3%(19/57)NRNR1.8%(1/57)NR29.8%(17/57)NRNRNR Taha \[[@CR9]\]Conservation44.3%(27/61)55.7%(34/61)NRNRNRNR4.9%(3/61)NRNRNROperative treatment studies Kim \[[@CR10]\]Three cannulated screwsNR0(0/58)0(0/58)1.9%(1/54)7.4%(4/54)NR6.9%(4/58)7.4%(4/54)35.2%(19/54)NR Manohara \[[@CR11]\]Cancellous screwsNR0(0/100)0(0/100)3%(3/100)5%(5/100)7%(7/100)18%(18/100)8%(8/100)44.1%(30/68)22.1%(15/68) Han \[[@CR12]\]Multiple screws, pins, or dynamic hip screwNR0(0/52)15.4%(8/52)NR11.5%(6/52)1.9%(1/52)3.8%(2/52)30.8%(16/52)NRNR Phillips \[[@CR13]\]Watson-Jones nail94.4%(68/72)0(0/72)5.6%(4/72)5.6%(4/72)22.5%(9/40)NR29.2%(21/72)9.7%(7/72)NRNR Lapidus \[[@CR14]\]Olmed screwsNR0(0/382)6.5%(25/382)NR5.2%(20/382)4.5%(17/382)21.5%(82/382)11.8%(45/382)NR5%(19/382) Rogmark \[[@CR15]\]Hansson hook pinsNR0(0/224)4.5%(10/224)7.1%(16/224)5.4%(12/224)11.2%(25/224)11.2%(25/224)15.2%(34/224)70.6%(72/102)36.4%(36/99) Chen \[[@CR16]\]Cancellous screws94.6% (35/37)5.4% (2/37)0(0/37)NR10.8% (4/37)NRNR16.2%(6/37)NR51.4(19/37) Chiu \[[@CR17]\]Knowles pins93.4%(285/305)0(0/305)5.6%(17/305)3.0%(9/305)7.2%(22/305)NR13.7%(50/366)12.8%(39/305)NR7.2%(22/305) Makki \[[@CR18]\]Dynamic hip screw96.8%(30/31)NR3.2%(1/31)NR3.2%(1/31)NR9.7%(3/31)0(0/31)NRNRDynamic hip screw with anti-rotation screw88.2%(30/34)NR11.8%(4/34)NR8.8%(3/34)NR2.9%(1/34)2.9%(1/34)NRNR Parker \[[@CR19]\]Screw fixationNR0(0/346)11%(38/346)NRNR1.7%(6/346)18.8%(65/346)14.5%(50/346)33.2%(115/346)NRHemiarthroplastyNR0.58%(2/346)3.8%(13/346)NRNR6.9%(24/346)25.7%(89/346)5.5%(19/346)19.1%(66/346)NR Stromqvist \[[@CR20]\]Hook pin fixationNRNR1.6%(1/64)NR3.1%(2/64)NR24.7%(21/85)NRNRNR Parker \[[@CR21]\]Three cannulated screwsNRNR8.5%(48/565)NRNRNRNRNRNRNR Parker \[[@CR22]\]Internal fixationNRNR2.7%(3/112)NR4.5%(5/112)NRNR4.5%(5/112)NRNR Yih \[[@CR23]\]Minimally invasive dynamic hip screw100%(33/33)NR0(0/33)0(0/33)12.1%(4/33)NR9.1%(3/33)3%(1/33)NRNRDynamic hip screw100%(25/25)NR0(0/25)0(0/25)12%(3/25)NR8%(2/25)4%(1/25)NRNRMultiple cannulated screws96.9%(31/32)NR3.1%(1/32)9.4%(3/32)21.9%(7/32)NR9.4%(3/32)15.6%(5/32)NRNR Hui \[[@CR24]\]Over 80 years internal fixationNR26.7%(4/15)NR6.7%(1/15)26.7%(4/15)NR17.2%(5/29)53.3%(8/15)NR6.7%(1/15)65 to 79 years internal fixationNR6.3%(1/16)NR0(0/16)0(0/16)NR25%(7/28)12.5%(2/16)NR12.5%(2/16)Over 80 years hemiarthroplastyNR8.7%(2/23)NR0(0/23)0(0/23)NR33.3%(19/57)13%(3/23)4.3%(1/23)4.3%(1/23) Bjorgul \[[@CR25]\]Cannulated screwsNR1.8%(4/225)7.1%(16/225)1.3%(3/225)4.4%(10/225)NR14.7%(33/225)18.7%(42/225)36.9%(83/225)2.7%(6/225) Watson \[[@CR26]\]Dynamic hip screwNRNRNRNR3.2%(1/31)9.7%(3/31)19.4%(6/31)3.2%(1/31)32.3%(10/31)32.3%(10/31)Cancellous screws.NRNRNRNR0(0/29)6.9%(2/29)20.7%(6/29)10.3%(3/29)31%(9/29)20.7%(6/29) Lee \[[@CR27]\]Dynamic hip screws84.8%(39/46)NR0(0/46)0(0/46)8.7%(4/46)NR6.5%(3/46)2.2%(1/46)NRNRMultiple cannulated screws77%(37/48)NR4.2%(2/48)6.3%(3/48)8.3%(4/48)NR4.2%(2/48)14.6%(7/48)NRNR Conn \[[@CR28]\]Three parallel 6.5-mm AONRNR6.4%(24/375)NR4%(15/375)3.7%(14/375)20.5%(77/375)5.1%(19/375)NRNR Sikand \[[@CR29]\]ConservationNRNRNRNRNRNR50%(4/8)NRNRNRHemiarthroplastyNRNRNRNRNR6.9%(2/29)37.9%(11/29)3.4%(1/29)37.9%(11/29)NRInternal fixationNRNRNRNRNR0.9%(1/110)15.5%(17/110)7.3%(8/110)39.1%(43/110)NR*NR* not recordBed rest-related complications: deep venous thrombosis, pneumonia, and urinary infection Table 3Demographics according to treatment groupVariableConservative treatmentSurgical treatment*P* valueCases11203951Mean age (years)75.0 ± 4.876.5 ± 4.1Female/Male598/1602555/1112Union68.8%(642/933)92.6%(635/686)\<0.001Secondary displacement and non-union30%(334/1112)0.57%(12/2124)\<0.001Avascular necrosis10.3%(39/380)7.7%(159/2074)0.09Bed rest-related complications11.4%(27/237)4.9%(106/2149)\<0.0011 year mortality14.7%(125/852)18%(598/3318)0.02Reoperation22.6%(157/696)10.6%(336/3155)\<0.001

Literature quality and the risk of bias {#Sec12}
---------------------------------------

Most studies scored moderately in terms of methodological quality. The overall score was 7.38 ± 1.37, rendering the outcomes susceptible to the risk of bias (Table [4](#Tab4){ref-type="table"}). The weighted kappa for agreement on trial quality between reviewers was 0.83 \[95% CI (0.72--0.92)\]. The biases included:Table 4Methodological quality of the included studies based on the modified CASPLiteraturesA focused issue with a questionMethod appropriatePatients recruited appropiatelyDefine the interventionOutcomes accurately measuredConfounding factors identifiedConfounding factors consideredFollow-up \>80%Results all clearly definedResults realistic?Applicable to local populationResults proportional to other evidenceTotalBentley \[[@CR1]\]11C.T11011111110Cserhati \[[@CR2]\]1101100001117Ma \[[@CR3]\]1000000101115Jensen \[[@CR4]\]1000101101117Buorda \[[@CR5]\]1010101111119Taha \[[@CR6]\]10C.T0000101115Raaymakers \[[@CR7]\]10C.T0001111117Raaymakers \[[@CR8]\]10C.T0001111117Verheyen \[[@CR9]\]1000001101116Rogmark \[[@CR10]\]1000101101117Lapidus \[[@CR11]\]10C.T0001111117Han \[[@CR12]\]1000001111117Phillips \[[@CR13]\]1010001011117Manohara \[[@CR14]\]1000101111118Kim \[[@CR15]\]1010101111119Chiu \[[@CR16]\]1010101101118Chen \[[@CR17]\]10C.T0001111117Makki \[[@CR18]\]1000101111118Parker \[[@CR19]\]1010101111119Stromqvist \[[@CR20]\]1000100101116Parker \[[@CR21]\]1010101111119Parker \[[@CR22]\]1010100101117Lee \[[@CR23]\]1010101111119Hui \[[@CR24]\]10C.T0000101115Bjorgul \[[@CR25]\]1010101101118Watson \[[@CR26]\]1010101111119Yih \[[@CR27]\]1000100101116Conn \[[@CR28]\]1010101111119Sikand \[[@CR29]\]1000001101116Mean1.000.070.380.070.620.000.760.930.5511.001.007.38*C.T* cannot tell Selection bias: The fact that few trials were typical RCTs may cause major selection bias. Inconsistencies in evaluation of the type of undisplaced FNF and patient age may constitute other sources of bias.Performance bias: This is attributable to the lack of rehabilitation programs. No consistent method was used for early weight-bearing facilitating recovery.Attrition bias: A small number of trials exhibited considerable loss to follow-up. Most studies reported outcomes incompletely.Detection bias: This may possibly be caused by non-standardized or undescribed follow-up schedules.Reporting bias: This is an intrinsic weakness of retrospective cohort studies.

In detail, we restricted the type of FNF to undisplaced fractures. Most studies contained patients with both undisplaced and displaced fractures. It was difficult to isolate data on undisplaced FNF; we therefore established strict selection and exclusion criteria to reduce selection bias as much as possible. Furthermore, differences in surgical methods increased performance bias. Inconsistencies in follow-up and loss to follow-up also increased bias. Most studies were retrospective in nature, rendering reporting bias unavoidable.

Pooled analysis {#Sec13}
---------------

As the measurements of patient characteristics and outcomes were consistent among the trials, we pooled these to derive mean values. Overall, surgically treated patients had a shorter time to weight-bearing and a shorter hospital stay. In addition, such patients had a higher union rate, lower rates of secondary displacement and non-union, and a lower rate of bed rest-related complications.

Significant differences were evident between the surgical and the conservative treatment groups in terms of the union rate (*p* \< 0.001), the rates of secondary displacement and non-union (*p* \< 0.001), and the rate of bed rest-related complications (*p* \< 0.001). A trend toward a difference in the AVN rate was also apparent (*p* = 0.09).

Discussion {#Sec14}
==========

To the best of our knowledge, this is the first systematic review to focus on the optimal treatment for undisplaced FNFs. We investigated whether conservative treatment was optimal for the common problem of undisplaced FNFs in the elderly. We developed explicit inclusion and exclusion criteria, assessed the methodological quality of all studies, explored the reproducibility of all selection and assessment criteria, performed quantitative analysis, and explored possible reasons for observed differences among studies. We found data paradox and confirmed the correct data of the original paper \[[@CR20]\]. The validity of our findings is strengthened by the fact that we strictly followed the suggestions of the Cochrane Handbook for Systematic Reviews of Interventions (version 5.0.2) and the PRISMA 2009 checklist.

One of our most important findings is that fractures that were surgically treated had higher union rates and comparable non-union rates to those treated conservatively. Obviously, fixation affords stability and stiffness, directly enhancing the strength of the femoral neck \[[@CR41], [@CR42]\]. Biomechanical studies have confirmed that fracture fixation and immobilization affect the pattern of skeletogenic stem cell differentiation into osteoblasts; mechanical fixation would obviously influence neovascularization \[[@CR43]\]. Thus, fixation promotes bone union. In some studies \[[@CR13]--[@CR15], [@CR20]\], the union rates reached 90%. Fixation failure is a rare complication after surgery to treat undisplaced fractures. The fixation failure rate in our meta-analysis was only 3.3% (45/1366).

Conservative treatment is an option for undisplaced FNFs, the advantage being that surgery is avoided, but most studies revealed a significant risk of displacement during non-operative treatment. The risk varied from 14.1 to 55.7% \[[@CR9]--[@CR12], [@CR26]--[@CR28]\]. Verheyen et al. \[[@CR28]\] explored the rate of secondary displacement in 105 patients. Forty-eight patients (46%) were at risk of such displacement; the patient group had a high mean age. Secondary displacement was more common in patients aged \>70 years, in agreement with the data of Raaymakers \[[@CR27]\], who reported secondary instability in 41% of patients \>70 years of age. In healthy patients \<70 years of age, the value was 7%. Secondary displacement is very rare after surgical treatment.

AVN is a well-recognized complication of FNFs, caused by alterations in the blood supply \[[@CR7], [@CR44]\]. AVN often develops 2--3 years after treatment. We found no significant difference between the two treatment groups in terms of AVN. However, AVN tended to be less common in surgical patients. Massive rupture of the retinacular vessels may occur when the femoral head is rotated during surgery; this may trigger AVN \[[@CR45]\]. Thus, fixation potentially adversely affects the vascularity of the femoral head \[[@CR46]\]. On the other hand, fixation prevents micromotion of the fracture site, facilitating vascularity. In Brodetti et al.'s cadaver experimental study \[[@CR47]\], they inserted nails or screws into various sites to observe changes in blood supply; they found that such insertions were unlikely to contribute to further devascularization of the femoral head. Bentley et al. \[[@CR15]\] followed up patients for \>3 years and found that, although no AVN occurred in the first year, AVN did develop after 2 years in both groups. The incidence did not vary greatly between those who underwent conservative (14%) and surgical (18%) treatment. Hence, follow-up is very important to AVN detection.

Re-operation to deal with complications is a commonly reported outcome measure. After conservative treatment, re-operations were principally attributable to secondary displacement and latent AVN \[[@CR11], [@CR28]\]. Non-union, fixation failure, and AVN were the most common reasons for re-operation after surgical treatment \[[@CR7]\]. The re-operation rate differed significantly (*p* \< 0.01) between the two treatment options. Overall, the outcomes were better after surgery. It is true that patients are exposed to extra risks (including anesthesia and bleeding) during surgery. We found no evidence suggesting that complications associated with anesthesia and surgery outweighed the increased risk of fracture-healing complications characteristic of conservative treatment. On the contrary, surgical treatment significantly reduced the risk of fracture displacement and significantly increased the union rate. Patients undergoing re-operation generally underwent hemiarthroplasty or arthroplasty \[[@CR7], [@CR11]\]. Overall, surgical treatment must be recommended.

Many clinical reports on treatment outcomes have focused on surgical rather than functional outcome measures. The objective functional results of various treatments are rarely assessed. The Harris hip score (HHS) is the most common modality used to assess hip function. In one study \[[@CR40]\] on patients aged \>60 years, Yih et al. reported an HHS of 84.2 ± 5.2 for those treated via insertion of dynamic hip screws and 82.6 ± 5.1 for those undergoing osteosynthesis using cannulated screws. Some studies employed fairly crude outcome measures (pain and mobility level documented in a rudimentary manner). In a recent study of 224 patients who completed self-evaluation questionnaires \>3 years after internal fixation, Rogmark et al. found that 40% reported average to severe pain when walking and 25% pain at rest. \[[@CR25]\] Functional results are rarely assessed in those treated conservatively. In one comparative study \[[@CR17]\], Cserhati et al. recorded the levels of pain and mobility. Of 39 patients, 5.6% (10/39) reported poorer mobility status after conservative treatment compared with 45.2% (28/62) of those who underwent surgery; 51.3% (20/39) of patients reported severe or moderate pain when weight-bearing after conservative treatment compared with 61.3% (38/62) of those who underwent surgical treatment. It thus seems that conservative treatment afforded better outcomes. In terms of mortality, this was higher (68%; 83/122) after conservative treatment than the 50.4% (63/125) after surgical treatment. Therefore, the overall outcome is better after surgical treatment.

In terms of surgery, primary hemiarthroplasty of an undisplaced FNF is a possible alternative treatment. Parker et al. \[[@CR37]\] randomized 692 patients with undisplaced FNFs to hemiarthroplasty (346 patients) or internal fixation (346 patients). Fixation was associated with a significantly reduced operative time (43 vs. 67 min), less blood loss, and a lower 1-year mortality rate (19 vs. 26%). The additional benefits of fixation were less pain at 1 year, less reduction in mobility, and a reduced dependence on walking aids. Re-operations were required by 5.5% (19/346) of the hemiarthroplasty group and 14.5% (50/346) of the fixation group. Hui et al. \[[@CR32]\] and Sikand et al. \[[@CR38]\] also evaluated re-operation and mortality levels. Internal fixation was associated with lower mortality but a greater need for re-operation, compared with hemiarthroplasty. The increased risk of mortality associated with hemiarthroplasty indicates that hemiarthroplasty cannot be recommended to treat an undisplaced FNF.

A precise diagnosis is important prior to choosing a treatment option. Radiography has certain limitations when used to distinguish FNF types, which can result in misdiagnosis. A patient may in fact have a displaced FNF but be diagnosed with an undisplaced one \[[@CR6], [@CR10]\]. In addition, diagnoses using the Garden classification are very inconsistent. Zlowodzki et al. \[[@CR48]\] surveyed the preferences of orthopedic surgeons in terms of FNF classification systems and asked whether they thought they could distinguish the four different Garden fracture types. Of all surgeons, 96% felt that they could distinguish between undisplaced (Garden I/II) and displaced (Garden III/IV) fractures. However, the Garden classification system exhibits great variability. Therefore, X-rays combined with a CT scan should be routinely used for diagnosis \[[@CR6]\].

We reviewed the conservative treatments employed \[[@CR9]--[@CR12], [@CR15], [@CR17], [@CR26]--[@CR28]\]. Careful nursing and optimal physician management allowed gradual mobilization to commence with exercises in bed, followed by partial weight-bearing, with the aid of crutches, for ≥8 weeks after fracture. The outcomes were satisfactory \[[@CR9], [@CR15]\]. However, only a few patients adhered to their rehabilitative protocols in the long term. If a patient without a comorbid condition can guarantee good compliance, conservative treatment may also be recommended. In addition, patients with surgical risks must be treated conservatively.

Our work had certain limitations: (1) Most studies were retrospective in nature. Ignoring such studies would have underpowered our analyses and negatively affected the accuracy of our findings. A future strictly designed and adequately powered RCT is essential. (2) We pooled Garden I and Garden II FNFs; their prognoses did not differ greatly. A future study could compare treatment outcomes between patients with these two types of FNF. (3) We explored possible publication bias using Begg, Egger, and funnel plots. The included studies did not meet the standards required by these methods; it was thus difficult to evaluate publication bias.

Ideally, a randomized trial would reveal whether surgical or conservative treatment should be preferred for undisplaced FNFs. We suggest that future studies should prospectively compare the outcomes and complication rates of different internal fixation techniques and conservative methods.

Conclusions {#Sec15}
===========

Surgery to treat undisplaced FNFs was associated with a higher union rate and a tendency toward reduction in the AVN rate. Careful treatment and follow-up are essential. We suggest that CT should be routinely used to assist in precise diagnosis. Follow-up should be maintained for at least 2 years, allowing AVN detection (if AVN develops) and treatment.

AVN

:   Avascular necrosis

FNF

:   Femoral neck fractures

HHS

:   Harris hip score
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